| Literature DB >> 34983375 |
Divya Arunachalam1,2, Shruthi Mahalakshmi Ramanathan1, Athul Menon3, Lekshmi Madhav3, Gopalakrishna Ramaswamy3, Venkatesh Prajna Namperumalsamy4, Lalitha Prajna5, Dharmalingam Kuppamuthu6,7,8.
Abstract
BACKGROUND: Aspergillus flavus, one of the causative agents of human fungal keratitis, can be phagocytosed by human corneal epithelial (HCE) cells and the conidia containing phagosomes mature into phagolysosomes. But the immunological responses of human corneal epithelial cells interacting with A. flavus are not clear. In this study, we report the expression of immune response related genes of HCE cells exposed to A. flavus spores using targeted transcriptomics.Entities:
Keywords: Aspergillus flavus; Corneal epithelial cells; Fungal keratitis; Immune response; NanoString analysis; Targeted transcriptomics
Mesh:
Substances:
Year: 2022 PMID: 34983375 PMCID: PMC8728928 DOI: 10.1186/s12864-021-08218-5
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Morphology of uninfected and A. flavus infected HCE cells. Microscopic images of primary HCE cells grown on 6-well culture plates were infected with (A) no infection (B) A. flavus CI1698 (C) A. flavus CI1123 and HCE cell line (RCB2280) infected with (D) no infection (E) A. flavus CI1698 (F) A. flavus CI1123 at 200X magnification. The arrow shows the A. flavus conidia
Fig. 2Colocalization of early and late endosomal markers with the A. flavus conidia. RCB2280 cells were infected with A. flavus (CI1698) swollen spores for 4 h and stained for endosomal markers. (A) A. flavus in early endosomes (CD71) (B) A. flavus in late endosomes (LAMP1). The endosomal markers (Red) were detected using dylight 550 conjugated goat anti-mouse secondary antibody. From left to right, panels show bright field, fluorescence image of the blue channel (DAPI), fluorescence image of red channel (endosomes), merged overlay of all fluorescent channels, White arrow shows the germinated conidia inside the early and late endosomes
Fig. 3Differential regulation of immune response genes in HCE cells in response to A. flavus. (a) Venn diagram shows the comparison of differentially expressed genes between RCB2280 cells and primary HCE cells infected with CI1698 and CI1123. (b) Bar graph for the up and down-regulated genes in RCB2280 cells and primary HCE cells infected with A. flavus
Fig. 4Scatter plot for the differentially expressed genes of HCE cells cocultured with CI1698. MA plot showing the mRNA abundance in (a) RCB2280 cells (b) primary HCE cells after infection with CI1698 for 6 h. Red dots - Up-regulation; Blue dots – Down-regulation; Grey dots- no change
Fig. 5Differentially expressed immune genes of RCB2280 cells exposed with CI1698. Bar graph representing up-regulated (red) and down-regulated (green) genes with corresponding fold change in RCB2280 cells infected with CI1698 for 6 h
Fig. 6Differentially expressed immune genes of primary HCE cells cocultured with CI1698. Bar graph representing up-regulated (red) and down-regulated (green) genes with corresponding fold change in primary HCE cells infected with CI1698 for 6 h
Functions of differentially expressed genes in HCE cells (cell line and primary) infected with A. flavus CI1698
| S.No | Gene symbol | Description | Function | Log2 Ratio | p value |
|---|---|---|---|---|---|
| 1 | CSF2 | Granulocyte-macrophage Colony stimulating factor 2 | growth and differentiation of hematopoietic precursor cells | 1.9681 | 0.0262 |
| 2 | TNFAIP3 | Tumor necrosis factor alpha-induced protein 3 | Inhibits NF-kB activity | 1.6228 | 0.0455 |
| 3 | LY96 | Lymphocyte antigen 96 | Innate immune responses | 1.5414 | 0.0219 |
| 4 | SLC2A1 | Solute carrier family 2, facilitated glucose transporter member 1 | Glucose transporter; Facilitate glucose transport to brain | 0.9197 | 0.0042 |
| 5 | IL3 | Interleukin 3 | Granulocyte-macrophage colony stimulating factors | 0.7921 | 0.0226 |
| 6 | ETS1 | Protein C-ets-1 | Transcription factor; Control expression of cytokines & chemokines | 0.5896 | 0.014 |
| 7 | NFIL3 | Nuclear factor interleukin-3- regulated protein | Transcription regulator; immune response | 0.581 | 0.0075 |
| 8 | NCAM1 | Neural cell adhesion molecule 1 | Neuron-neuron adhesion, neurite fasciculation, outgrowth of neurites etc. | 0.5205 | 0.0279 |
| 9 | CDH5 | Cadherin 5 | Cell-cell adhesion; cell-cell junction assembly | 0.3546 | 0.0378 |
| 10 | ICAM1 | Intracellular adhesion molecule 1 | Transmembrane signaling receptor activity | 0.285 | 0.0164 |
| 11 | RUNX1 | Runt-related transcription factor 1 | Attenuator of NF-kB signaling | 0.2612 | 0.0487 |
| 12 | FN1 | Fibronectin 1 | Cell adhesion; cell motility; wound healing; cell shape maintenance | 0.236 | 0.019 |
| 13 | NT5E | 5’-nucleotidase | Nucleosidase activity; hydrolyze extracellular nucleotides | 0.221 | 0.0008 |
| 14 | PLAUR | Urokinase plasminogen activator surface receptor | Promote plasmin formation | 0.2182 | 0.0428 |
| 15 | NOTCH2 | Neurogenic locus notch homolog protein 2 | Regulate cell-fate determination | 0.2014 | 0.044 |
| 16 | CD3EAP | DNA-directed RNA polymerase I subunit RPA34 | DNA-directed 5’-3’ RNA polymerase activity; RNA binding | 0.1774 | 0.0483 |
| 1 | CD6 | T-cell differentiation antigen CD6 | Regulate inflammatory responses; secretion of proinflammatory cytokines to LPS | 3.1751 | 0.0044 |
| 2 | CD5 | CD5 antigen like | Regulate inflammatory responses | 2.174 | 0.0093 |
| 3 | IL23R | Interleukin 23 R | Mediates stimulation of T-cells, NK-cells, macrophages via JAK-STAT signaling | 0.7777 | 0.0125 |
| 4 | PLAUR | Urokinase plasminogen activator surface receptor | Promote plasmin formation | 0.5552 | 0.0354 |
| 5 | ETS1 | Protein C-ets-1 | Transcription factor; Control expression of cytokines & chemokines | 0.4657 | 0.0471 |
| 6 | HLA-DMA | HLA class II histocompatibility antigen, DM alpha chain | Antigen processing and presentation | 0.3909 | 0.0347 |
| 7 | TICAM1 | TIR-domain containing adapter molecule 1 | TLR signaling | 0.3236 | 0.0134 |
| 8 | LGALS3 | Galectin 3 | Ligand for galactose. Innate immune response | 0.0466 | 0.048 |
| 1 | JAK1 | Tyrosine protein kinase 1 | IFN-alpha/beta/gamma signaling pathway | -0.1963 | 0.042 |
| 2 | SLAMF7 | SLAM family member 7 | Modulate activation and differentiation of various immune cells | -0.3343 | 0.0348 |
| 3 | LILRA5 | Leukocyte immunoglobulin-like receptor subfamily A member 5 | Triggering innate immune responses | -0.6356 | 0.0194 |
| 4 | IL19 | Interleukin 19 | Inflammatory responses | -0.7323 | 0.009 |
| 5 | LTB4R2 | Leukotriene B4 receptor 2 | Receptor for leukotrienes; mediates chemotaxis | -0.9056 | 0.0358 |
| 6 | ITGA2B | Integrin alpha-IIb | Integrin mediated signaling | -0.9215 | 0.0124 |
| 7 | C9 | Complement component 9 | Regulation of complement activation | -1.2485 | 0.0241 |
| 8 | IKZF3 | Zinc finger protein aiolos | Regulation of lymphocyte differentiation | -1.4196 | 0.0209 |
| 9 | LILRB2 | Leukocyte immunoglobulin-like receptor subfamily B member 2 | Down regulation of immune responses and development of tolerance | -2.5436 | 0.027 |
| 1 | XCR1 | Chemokine XC receptor 1 | Calcium mediated signaling; immune and inflammatory responses | -0.5621 | 0.0201 |
| 2 | LILRA4 | Leukocyte immunoglobulin-like receptor subfamily A member 4 | Triggering innate immune responses | -0.7656 | 0.0259 |
| 3 | KLRC3 | NKG2-E type II integral membrane protein | Receptor for recognition of MHC class I molecules by NK cells and Tc cells | -0.9674 | 0.033 |
| 4 | JAK3 | Tyrosine protein kinase 3 | Mediates signaling event in both innate and adaptive immunity | -1.0351 | 0.0199 |
Fig. 7KEGG pathway analysis of up and down-regulated genes of HCE cells infected with CI1698. (a) RCB2280 cells infected with CI1698 for 6 h. (b) Primary HCE cells infected with CI1698 for 6 h. Red bar - pathways associated with up-regulated genes; Green bar - pathways associated with down-regulated genes
Fig. 8The functionally grouped network of Gene Ontology enrichment analysis. Differentially expressed mRNA transcripts of RCB2280 cells and primary HCE cells infected with CI1698 using FunRich 3.1.3 and Cytoscape 3.8.1 tool. Green circle - RCB2280 cells infected with CI1698; Blue circle - primary HCE cells infected with CI1698; Red rectangle - Biological pathways
Fig. 9Scatter plot for the differentially expressed genes of HCE cells cocultured with CI1123. MA plot showing the mRNA abundance in (a) RCB2280 cells (b) primary HCE cells after infection with CI1123 for 6 h. Red dots - Up-regulation; Blue dots – Down-regulation; Grey dots - no change
Fig. 10Differentially expressed immune genes of RCB2280 cells exposed with CI1123. Bar graph representing up-regulated (red) and down-regulated (green) genes with corresponding fold change in RCB2280 cells infected with CI1123 for 6 h
Fig. 11Differentially expressed immune genes of primary HCE cells cocultured with CI1123. Bar graph showing up-regulated (red) and down-regulated (green) genes with corresponding fold change in primary HCE cells infected with CI1123 for 6 h
Functions of differentially expressed genes in HCE cells (cell line and primary) infected with A. flavus CI1123
| S.No | Gene symbol | Description | Function | Log2 Ratio | p value |
|---|---|---|---|---|---|
|
| |||||
| 1 | IL8 | Interleukin 8 | Chemotactic factor that attracts neutrophils, basophils and T-cells. It is released from several cell types upon inflammatory stimulus | 1.93500 | 0.0372 |
| 2 | TNFAIP3 | Tumor necrosis factor alpha-induced protein 3 | Inhibits NF-kB activity | 1.44080 | 0.0441 |
| 3 | IL23A | Interleukin 23 A | Involve in innate and adaptive immunity; IL17 signaling | 0.56002 | 0.0033 |
| 4 | IL6 | Interleukin 6 | Inducer of acute phase response; lymphocyte, monocyte differentiation | 0.51664 | 0.0276 |
| 5 | ETS1 | Protein C-ets-1 | Transcription factor; Control expression of cytokines & chemokines | 0.45335 | 0.0231 |
| 6 | NFKBIA | NF-kappa B inhibitor alpha | Inhibits nucleus translocation of NF-kB/Rel complexes | 0.44790 | 0.0051 |
| 7 | DUSP4 | Dual specificity protein phosphatase 4 | Regulates mitogenic signal transduction | 0.35252 | 0.0189 |
| 8 | SLC2A1 | Solute carrier family 2, facilitated glucose transporter member 1 | Glucose transporter; Facilitate glucose transport to brain | 0.34897 | 0.0437 |
| 9 | RUNX1 | Runt-related transcription factor 1 | Attenuator of NF-kB signaling | 0.33727 | 0.0074 |
| 10 | CD14 | Monocyte differentiation antigen CD14 | Innate immune response to bacterial LPS | 0.32269 | 0.0433 |
| 11 | ICAM1 | Intracellular adhesion molecule 1 | Transmembrane signaling receptor activity | 0.29601 | 0.0193 |
| 12 | IL4R | Interleukin 4 receptor | Receptor for IL-4 and IL-13; chemokine production | 0.28525 | 0.0355 |
| 13 | CTSS | Cathepsin S | Maturation of phagosomes | 0.12044 | 0.0231 |
| 14 | PSMD7 | 26 S proteasome non-ATPase regulatory subunit 7 | Degradation of ubiquitinated proteins | 0.10129 | 0.0277 |
|
| |||||
| 1 | CLEC4A | C-type lectin domain family 4 member A | Binds to mannose and fucose; regulate immune reactivity | 0.675 | 0.0303 |
| 2 | IL1RL1 | Interleukin 1 receptor-like 1 | Receptor for IL-33; Involve in helper T-cell function | 0.4157 | 0.0296 |
| 3 | BCL6 | B-cell lymphoma 6 protein | Transcriptional repressor mainly required for germinal center (GC) formation and antibody affinity maturation | 0.2613 | 0.0362 |
| 4 | LGALS3 | Galectin 3 | Ligand for galactose. Innate immune response | 0.1357 | 0.006 |
|
| |||||
| 1 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | Enhances BCL10 induced activation of NF-kB | -0.1295 | 0.0486 |
| 2 | KIR_Activating_ Subgroup_1 | Killer-cell immunoglobulin-like receptor activating subgroup I | Suppress cytotoxic activity of NK cells | -0.2670 | 0.0107 |
| 3 | HAVCR2 | Hepatitis A virus cellular receptor 2 | Modulate innate and adaptive immune response | -0.3465 | 0.0210 |
| 4 | TIRAP | Toll/interleukin-1 receptor domain-containing adapter protein | Adapter involved in TLR-2 & TLR4 signaling pathways | -0.6289 | 0.0251 |
| 5 | IL1RN | Interleukin 1 receptor antagonist protein | Inhibits activity of interleukin 1 | -0.6912 | 0.0456 |
| 6 | AIRE | Autoimmune regulator | Transcription factor; promote self-tolerance in thymus | -0.7154 | 0.0038 |
| 7 | IKZF3 | Zinc finger protein aiolos | Regulation of lymphocyte differentiation | -0.7239 | 0.0202 |
| 8 | CD45R0 | Receptor type tyrosine protein phosphatase C | T cell activation | -0.7606 | 0.0452 |
|
| |||||
| 1 | MAPK1 | Mitogen activated protein kinase 1 | cell growth, adhesion, survival and differentiation | -0.2363 | 0.0038 |
| 2 | LTB4R | Leukotriene B4 receptor 1 | Chemoattractant | -0.4182 | 0.0314 |
| 3 | CCL19 | C-C motif chemokine 19 | Chemotactic activity for T cells and B cells | -0.7688 | 0.0108 |
| 4 | IRGM | Immunity-related GTPase family M protein | Regulate autophagy and proinflammatory cytokine production | -0.7853 | 0.0258 |
| 5 | KIR_Activating_ subgroup I | Killer-cell immunoglobulin-like receptor activating subgroup I | Suppress cytotoxic activity of NK cells | -0.8292 | 0.0249 |
| 6 | IL20 | Interleukin 20 | Proinflammatory and angiogenic cytokine | -0.873 | 0.047 |
| 7 | LILRB2 | Leukocyte immunoglobulin-like receptor subfamily B member 2 | Down regulation of immune responses and development of tolerance | -2.0416 | 0.0376 |
Fig. 12KEGG pathway analysis of up and down-regulated genes of HCE cells infected with CI1123 for 6 h. (a) RCB2280 cells infected with CI1123. (b) Primary HCE cells infected with CI1123. Red bar - pathways associated with up-regulated genes; Green bar - pathways associated with down-regulated genes
Fig. 13The functionally grouped network of Gene Ontology enrichment analysis. Differentially expressed mRNA transcripts of RCB2280 cells and primary HCE cells infected with CI1123 using FunRich 3.1.3 and Cytoscape 3.8.1 tool. Purple circle - RCB2280 cells infected with CI1698; Blue circle - primary HCE cells infected with CI1123; Red rectangle -Biological pathways
Commonly altered genes in HCE cells (cell line and primary) by CI1698 and CI1123
| S. No | Genes | Description | Function |
|---|---|---|---|
| 1 | TNFAIP3 | Tumor necrosis factor alpha-induced protein 3 | Inhibits NF-kB activity |
| 2 | ETS1 | Protein C-ets-1 | Transcription factor; Control expression of cytokines & chemokines |
| 3 | SLC2A1 | Solute carrier family 2, facilitated glucose transporter member 1 | Glucose transporter; Facilitate glucose transport to brain |
| 4 | RUNX1 | Runt-related transcription factor 1 | Attenuator of NF-kB signaling |
| 5 | ICAM1 | Intracellular adhesion molecule 1 | Transmembrane signaling receptor activity |
| 6 | LGALS3 | Galectin 3 | Ligand for galactose. Innate immune response |
| 7 | IKZF3 | Zinc finger protein aiolos | Regulation of lymphocyte differentiation |
| 8 | LILRB2 | Leukocyte immunoglobulin-like receptor subfamily B member 2 | Down regulation of immune responses and development of tolerance |
Fig. 14Pathway analysis of HCE cells in response to A. flavus clinical isolates. (a) Biological pathways of RCB2280 cells infected with CI1698 and CI1123 for 6 h. Grey bar - RCB2280 cells infected with CI1123; Black bar - RCB2280 cells infected with CI1698. (b) Biological pathways of primary HCE cells infected with CI1698 and CI1123. Dark green bar - Primary HCE cells infected with CI1123; Light green bar - Primary HCE cells infected with CI1698. (c) Up-regulated immune genes associated pathways in HCE cells infected with A. flavus clinical isolates. (d) Down-regulated immune genes associated pathways in HCE cells infected with A. flavus clinical isolates
Fig. 15Expression of IL-8 in RCB2280 cells infected with CI1123. RCB2280 cells were cultured in 12-well plate till confluency and infected with CI1123 for 12 h, 16 h, 20h and 24 h. Bar graph representing the concentration of IL-8 at different time point. Black bar -Control; Grey bar - RCB2280 cells infected with CI1123. The data were analyzed using two-way ANOVA with Bonferroni multiple comparison test (ns-no significance; **** p<0.0001)